A COA is important batch evidence, but it should be reviewed with supplier identity, manufacturing-site evidence, GMP documentation, specification, impurity data, stability support, regulatory-file access, sample testing and shipment records
doi: 10.1016/j.jneb.2009.03.001
Understanding your province's formulary status and approval process is essential before initiating treatment
doi: 119
doi: 10.1002/bdr2.1088 Summary Keywords diabetes, pregnancy, systematic review, GLP-1 agonist, SGLT2 inhibitor, lactation Citation Muller DRP, Stenvers DJ, Malekzadeh A, Holleman F, Painter RC and Siegelaar SE (2023) Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence